Vaughan L, Fischer R W, Zimmermann D R, Winterhalter K H
FEBS Lett. 1984 Jul 23;173(1):173-8. doi: 10.1016/0014-5793(84)81041-8.
The rates of nonenzymatic glucosylation of albumin, high density lipoprotein (HDL) and low density lipoprotein (LDL) were determined in vitro using [14C]glucose repurified by a new and rapid HPLC method. All commercial preparations were found to contain contaminants reacting 15-20-times faster with protein than the repurified [14C]glucose. Removal of contaminants was critical to the rate determinations and constitutes a substantial improvement over the widely used existing method. The initial rates of nonenzymatic glucosylation determined in vitro for albumin, HDL and LDL were used to predict normal in vivo levels of 0.40, 0.65 and 0.08 mol glucose per mol protein, respectively. This is within the range of values found in vivo for albumin and LDL, but low for HDL. These values would be expected to increase 2-4-fold in diabetes.
使用一种新的快速高效液相色谱法重新纯化的[14C]葡萄糖,在体外测定白蛋白、高密度脂蛋白(HDL)和低密度脂蛋白(LDL)的非酶糖基化速率。发现所有市售制剂都含有污染物,这些污染物与蛋白质反应的速度比重新纯化的[14C]葡萄糖快15至20倍。去除污染物对于速率测定至关重要,并且相对于广泛使用的现有方法有实质性改进。体外测定的白蛋白、HDL和LDL非酶糖基化的初始速率分别用于预测体内正常水平,即每摩尔蛋白质含0.40、0.65和0.08摩尔葡萄糖。这在体内白蛋白和LDL的测定值范围内,但对于HDL而言较低。预计这些值在糖尿病患者中会增加2至4倍。